ScholarIQanswers from OpenAlex

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy

PaperCitations, authors & open-access status

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy have?

ScholarIQcitation count

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy has 78 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy published?

ScholarIQyear

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy has 2002 year in the ScholarIQ index.

What is the open-access status of Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy?

ScholarIQoa status

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy has closed oa status in the ScholarIQ index.

What is the DOI of Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy?

ScholarIQdoi

The DOI for Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy is on the source record.

What is the PMID of Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy?

ScholarIQpmid

The PMID for Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy is on the source record.

What is the OpenAlex record for Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy?

ScholarIQopenalex

The OpenAlex for Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial